glp 1 agonist dementia Can GLP-1 agonists and SGLT-2 inhibitors decrease risk?, Two recent JAMA Neurology studies examined the association., Read the Original Investigation “Cardioprotective Glucose-Lowering Agents An analysis on the role

2.1 Role of PDEs in schizophrenia Among the eleven PDE families, PDE1B and PDE10A have emerged as especially relevant in the context of schizophrenia due to their high expression in striatal and cortical circuits governing dopaminergic neurotransmission (Nishi and Snyder, 2010

Poli V, Zanoni I

Clinical evidence for oral glutathione and skin lightening exists, including a randomized controlled trial that found 250 mg/day significantly reduced melanin index after four weeks of administration

Intraoperative opioids use for laryngeal squamous cell carcinoma surgery and recurrence: a retrospective study

PMID: 37508253

Neutral conditions are easy mode for this peptide